We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Factors Associated With Inadequate Effectiveness of a Multidisciplinary Disease Management Program in Heart Failure Patients Stratified by Galectin 3 Level.
- Authors
Liu, Min-Hui; Wang, Chao-Hung; Chiou, Ai-Fu; Yang, Ning-I; Kuo, Li-Tang
- Abstract
Objective: This study investigated whether multidisciplinary disease management programs (MDPs) exert the same effects in heart failure (HF) patients across risk levels stratified by galectin-3 (Gal-3) level and what factors are associated with inadequate effectiveness of MDP. Methods: We used a longitudinal follow-up design based on a previous randomized trial. A total of 355 stabilized hospitalized HF patients were enrolled. The effects of MDP on death and HF-related rehospitalization were analyzed according to Gal-3 levels. Results: During the 4-year follow-up, Gal-3 levels predicted mortality and composite events (p < .001). Multivariable analysis demonstrated the event-lowering effect of MDP (hazard ratio [HR] = 0.49, p = .001 for death and HR = 0.50, p < .001 for composite events). However, the effect of MDP was inadequate for those with high Gal-3 levels (≥17.9 ng/ml), whose 4-year composite event rate was 43% in the MDP arm. Further analysis showed that, in patients with Gal-3 ≥ 17.9 ng/ml, the independent factors associated with a high composite event rate were no MDP, older age, worse New York Heart Association functional class, no angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker use, higher predischarge natriuretic peptide levels, and wider QRS complexes. Conclusions: The effectiveness of MDP for HF patients at high risk was inadequate. Our findings identified the characteristics of these MDP nonresponders. Better integration of advanced care plans based on strategies guided by Gal-3 level is needed to improve care quality.
- Subjects
TAIWAN; ENZYME analysis; HEART failure treatment; ADRENERGIC beta blockers; AGE distribution; ACE inhibitors; BIOMARKERS; BLOOD testing; C-reactive protein; CHI-squared test; CONFIDENCE intervals; HEALTH care teams; HEART failure; LONGITUDINAL method; MORTALITY; MULTIVARIATE analysis; PROTEINS; RESEARCH funding; STATISTICAL sampling; STATISTICS; SURVIVAL; T-test (Statistics); DISEASE management; BODY mass index; CONTROL groups; PROPORTIONAL hazards models; DESCRIPTIVE statistics; KAPLAN-Meier estimator; PROGNOSIS
- Publication
Biological Research for Nursing, 2017, Vol 19, Issue 1, p77
- ISSN
1099-8004
- Publication type
Article
- DOI
10.1177/1099800416659743